Photodynamic therapy simplified: nonprepared, moderate-grade actinic keratosis lesions respond equally well to 5-aminolaevulinic acid patch photodynamic therapy as do mild lesions.
Department of Dermatology and Allergology, Klinikum Vest Academic Teaching Hospital, Dorstener Strasse 151, D-45657, Recklinghausen, Germany.
R M
RM
Szeimies
Department of Dermatology, University of Kiel, Schittenhelmstr.7, D-24105, Kiel, Germany.
A
A
Hauschild
das forschungsdock®, Eidelstedter Weg 1, D-22869, Schenefeld, Germany.
C
C
Ortland
photonamic GmbH & Co. KG, Theaterstrasse 6, D-22880, Wedel, Germany.
A C E
AC
Moor
photonamic GmbH & Co. KG, Theaterstrasse 6, D-22880, Wedel, Germany.
M
M
Stocker
Universitätsspital Basel, Dermatologische Universitätsklinik, Petersgraben 4, CH-4031, Basel, Switzerland.|UniversitätsSpital Zürich, Dermatologische Klinik, Gloriastrasse 31, CH-8091, Zürich, Switzerland.
C
C
Surber
D000622:Aminolevulinic Acid / Q000008:administration & dosage*; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D055623:Keratosis, Actinic / Q000188:drug therapy*; D010778:Photochemotherapy / Q000379:methods*; D017319:Photosensitizing Agents / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D057968:Transdermal Patch; D016896:Treatment Outcome
D017319:Photosensitizing Agents; D000622:Aminolevulinic Acid